Start free

Grace Therapeutics, Inc. (GRCE) insider trading

Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Nov 18, 2026.

Filings shown
20
Open-market buys
25
Open-market sells
0
Buys, 10b5-1 box not checked
25 of 25

Counts cover the 20 most recent Form 4 filings Tradune holds for GRCE (filed Aug 19 – Nov 18, 2026); the score below covers only the trailing 90 days (24 buys, 0 sells). SEC EDGAR Form 4 filings for GRCE last checked Nov 21, 2026, 09:00 UTC; the latest GRCE filing Tradune holds was filed Nov 18, 2026. This is not guaranteed to be the complete record — see GRCE's full Form 4 filing history on SEC EDGAR.

Open-market activity, last 90 days

Purchases (Form 4 code P) and sales (code S) on the 19 filings Tradune holds for GRCE filed Sep 1 – Nov 18, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.

Open-market purchases and sales by insider
Insider Buys Sells Shares bought Shares sold Value
Opaleye Management Inc.10% owner 23 0 342,913 — +$652,723
Prashant KohliChief Executive Officer 1 0 100,000 — +$214,000

Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.

Insider-activity score

78/ 100

Purchase cluster incl. officer
2 distinct buyers24 buy · 0 sell txofficer buying

Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →

Get alerted when insiders buy the stocks you own

Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.

Free for everyone right now · no card · nothing to buy

Start free

How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).

Insider Buying at GRCE

Insiders reported 25 open-market purchases of GRCE between Aug 19, 2026 and Nov 18, 2026, across 2 distinct buyers. The most recent purchase was reported by Opaleye Management Inc. (10% owner) on Nov 18, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.

Recent Form 4 filings

Source: SEC EDGAR Form 4 · transaction codes explained

Opaleye Management Inc. 10% owner · filed Nov 18, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 2,974 $1.73 3,102,904 (indirect) +0.1% Nov 18, 2026
Open-market purchase 10b5-1 box not checked 29,207 $1.72 3,099,930 (indirect) +1.0% Nov 17, 2026
Open-market purchase 10b5-1 box not checked 15,879 $1.76 3,070,723 (indirect) +0.5% Nov 16, 2026

† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.

“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.

Opaleye Management Inc. 10% owner · filed Nov 5, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 3,087 $1.77 3,054,853 (indirect) +0.1% Nov 5, 2026
Open-market purchase 10b5-1 box not checked 5,027 $1.80 3,051,766 (indirect) +0.2% Nov 4, 2026
Open-market purchase 10b5-1 box not checked 10,328 $1.79 3,046,739 (indirect) +0.3% Nov 3, 2026
Opaleye Management Inc. 10% owner · filed Oct 26, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 66,411 $1.77 3,036,411 (indirect) +2.2% Oct 26, 2026
Open-market purchase 10b5-1 box not checked 21,390 $1.93 2,970,000 (indirect) +0.7% Oct 22, 2026
Opaleye Management Inc. 10% owner · filed Oct 21, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 4,256 $1.88 2,948,610 (indirect) +0.1% Oct 19, 2026
Opaleye Management Inc. 10% owner · filed Oct 16, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 36,347 $1.89 2,944,354 (indirect) +1.2% Oct 16, 2026
Open-market purchase 10b5-1 box not checked 23,485 $1.95 2,908,007 (indirect) +0.8% Oct 15, 2026
Open-market purchase 10b5-1 box not checked 11,233 $1.93 2,884,522 (indirect) +0.4% Oct 14, 2026
Opaleye Management Inc. 10% owner · filed Oct 13, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 7,215 $2.02 2,873,289 (indirect) +0.3% Oct 12, 2026
Open-market purchase 10b5-1 box not checked 5,340 $2.04 2,866,074 (indirect) +0.2% Oct 9, 2026
Open-market purchase 10b5-1 box not checked 2,077 $2.02 2,860,734 (indirect) +0.1% Oct 8, 2026
Opaleye Management Inc. 10% owner · filed Oct 5, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 1,694 $2.06 2,858,657 (indirect) +0.1% Oct 5, 2026
Open-market purchase 10b5-1 box not checked 20,000 $2.07 2,856,963 (indirect) +0.7% Oct 2, 2026
Open-market purchase 10b5-1 box not checked 38,796 $2.04 2,836,963 (indirect) +1.4% Oct 1, 2026
Opaleye Management Inc. 10% owner · filed Oct 1, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 7,849 $2.09 2,798,167 (indirect) +0.3% Sep 29, 2026
Opaleye Management Inc. amended 10% owner · filed Oct 1, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 5,318 $2.10 2,790,318 (indirect) +0.2% Sep 23, 2026
Open-market purchase 10b5-1 box not checked 9,771 $2.10 2,785,000 (indirect) +0.4% Sep 21, 2026
Edward Neugeboren Director · filed Sep 21, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (Right to Buy) 12,200 — — — Sep 17, 2026
A. Brian Davis Director · filed Sep 21, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (Right to Buy) — — — — Sep 17, 2026
Vimal Kavuru Director · filed Sep 21, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (Right to Buy) 12,200 — — — Sep 17, 2026
George Kottayil Director · filed Sep 21, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (Right to Buy) 12,200 — — — Sep 17, 2026
Opaleye Management Inc. 10% owner · filed Sep 10, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 5,836 $2.09 2,775,229 (indirect) +0.2% Sep 9, 2026
Open-market purchase 10b5-1 box not checked 9,393 $2.10 2,769,393 (indirect) +0.3% Sep 8, 2026
Prashant Kohli Chief Executive Officer · filed Sep 10, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 100,000 $2.14 121,357 +468% Sep 9, 2026
Prashant Kohli Chief Executive Officer · filed Sep 1, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (Right to Buy) 267,160 — — — Aug 28, 2026
Amresh Kumar VP Program Management · filed Sep 1, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (Right to Buy) 35,760 — — — Aug 28, 2026
R. Loch Macdonald Chief Medical Officer · filed Sep 1, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (Right to Buy) 54,690 — — — Aug 28, 2026
Robert J. DelAversano Principal Financial Officer · filed Sep 1, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (Right to Buy) 33,660 — — — Aug 28, 2026
Opaleye Management Inc. 10% owner · filed Aug 19, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 11,608 $2.09 2,760,000 (indirect) +0.4% Aug 14, 2026

Insider filings reported around the same time

Other companies whose most recent Form 4 was filed closest to GRCE's (Nov 18, 2026).

Frequently asked about GRCE insider activity

How many insiders bought GRCE stock in these Form 4 filings?

2 distinct insiders at Grace Therapeutics, Inc. reported 25 open-market purchases (Form 4 code P) of GRCE shares between Aug 19, 2026 and Nov 18, 2026, the most recent filed by Opaleye Management Inc. (10% owner) on Nov 18, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.

Who filed the most recent Form 4 for GRCE?

The most recent Form 4 on this page was filed by Opaleye Management Inc. (10% owner) on Nov 18, 2026, reporting 3 transactions. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.

What was the largest open-market GRCE insider purchase shown?

The largest open-market purchase among the filings shown was 100,000 GRCE shares at $2.14 (about $214,000) by Prashant Kohli (Chief Executive Officer) on Sep 9, 2026. Value is shares × the price reported on the Form 4; its Rule 10b5-1 box is not checked.

Do the recent GRCE insider purchases have the Form 4 10b5-1 box checked?

No. All 25 GRCE open-market purchases shown were reported with the Rule 10b5-1 box not checked. A blank box records what the filer disclosed; it does not prove that no plan exists. Latest: Opaleye Management Inc. (10% owner) on Nov 18, 2026, 2,974 shares.

New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.

Get insider alerts for GRCE — and your whole portfolio

Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy

This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.

Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.